Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fukasawa

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Oncogene|April 20, 1999
Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpressionP E Carroll, M Okuda, H F Horn, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 23, 1998
[Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor]K Kuroda, N Ishii, K Fukasawa, et al.
Biochemistry|February 28, 1995
Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MSK A Resing, S J Mansour, A S Hermann, et al.
Oncogene|October 19, 1995
Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA bindingK Fukasawa, R Zhou, W T Matten, et al.
Journal of Medicinal Chemistry|December 14, 2001
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residuesT Honma, T Yoshizumi, N Hashimoto, et al.
Biochemistry|September 26, 2001
Characterization of the metal-substituted dipeptidyl peptidase III (rat liver)J Hirose, H Iwamoto, I Nagao, et al.
Journal of Medicinal Chemistry|December 14, 2001
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library designT Honma, K Hayashi, T Aoyama, et al.
Cell|October 29, 2000
Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplicationM Okuda, H F Horn, P Tarapore, et al.
Science (New York, N.Y.)|May 23, 1998
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factorN S Duesbery, C P Webb, S H Leppla, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Oncogene|April 20, 1999
Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpressionP E Carroll, M Okuda, H F Horn, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 23, 1998
[Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor]K Kuroda, N Ishii, K Fukasawa, et al.
Biochemistry|February 28, 1995
Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MSK A Resing, S J Mansour, A S Hermann, et al.
Oncogene|October 19, 1995
Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA bindingK Fukasawa, R Zhou, W T Matten, et al.
Journal of Medicinal Chemistry|December 14, 2001
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residuesT Honma, T Yoshizumi, N Hashimoto, et al.
Biochemistry|September 26, 2001
Characterization of the metal-substituted dipeptidyl peptidase III (rat liver)J Hirose, H Iwamoto, I Nagao, et al.
Journal of Medicinal Chemistry|December 14, 2001
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library designT Honma, K Hayashi, T Aoyama, et al.
Cell|October 29, 2000
Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplicationM Okuda, H F Horn, P Tarapore, et al.
Science (New York, N.Y.)|May 23, 1998
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factorN S Duesbery, C P Webb, S H Leppla, et al.
Pageof 9